Glucose variability
- PMID: 23613565
- PMCID: PMC3636651
- DOI: 10.2337/db12-1396
Glucose variability
Abstract
The proposed contribution of glucose variability to the development of the complications of diabetes beyond that of glycemic exposure is supported by reports that oxidative stress, the putative mediator of such complications, is greater for intermittent as opposed to sustained hyperglycemia. Variability of glycemia in ambulatory conditions defined as the deviation from steady state is a phenomenon of normal physiology. Comprehensive recording of glycemia is required for the generation of any measurement of glucose variability. To avoid distortion of variability to that of glycemic exposure, its calculation should be devoid of a time component.
Figures





References
-
- The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986 - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes (UKPDS33). Lancet; 1998;352:837–853 - PubMed
-
- Hirsch IB, Brownlee M. Should minimal BG variability become the gold standard of glycemic control? J Diabetes Complications 2005;19:178–181 - PubMed
-
- Trence DL, Hirsch IB. Motherhood, apple pie, hemoglobin A(1C), and the DCCT. Endocr Pract 2012;18:78–84 - PubMed
-
- Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN; DCCT/EDIC Research Group Effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trial—revisited. Diabetes 2008;57:995–1001 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical